The study found that KRAS-LKB1 mutant lung cancer silenced the STING pathway owing to intrinsic mitochondrial dysfunction, resulting in a more aggressive and metastatic phenotype, significantly reduced survival rate, and drug sensitivity [27, 28]. Here, KRAS is linked to lung cancer.